Certified Global Research Member

Isomar 1

Iso 1

Key Questions Answered

Global Market Outlook
In-depth analysis of global and regional trends
Analyze and identify the major players in the market, their market share, key developments, etc.
To understand the capability of the major players based on products offered, financials, and strategies.
Identify disrupting products, companies, and trends.
To identify opportunities in the market.
Analyze the key challenges in the market.
Analyze the regional penetration of players, products, and services in the market.
Comparison of major players’ financial performance.
Evaluate strategies adopted by major players.
Recommendations

Why Choose Market Research Future?

Vigorous research methodologies for specific market.
Knowledge partners across the globe
Large network of partner consultants.
Ever-increasing/ Escalating data base with quarterly monitoring of various markets
Trusted by fortune 500 companies/startups/ universities/organizations
Large database of 5000+ markets reports.
Effective and prompt pre- and post-sales support.

Pdf download 3

Nephrectomy Market Research Report Information by Procedure (Open Nephrectomy, Laparoscopic nephrectomy, Robot-assisted Laparoscopic Surgery), Indication (Kidney Cancer and Kidney Disease), End User (Hospitals & Clinics, Surgical Centers) and Region (Americas, Europe, Asia-Pacific and Rest of the World) - Forecast till 2032

ID: MRFR/MED/3913-CR | 110 Pages | Author: Kinjoll Dey| December 2019

Leading companies partner with us for data-driven Insights

Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

1 EXECUTIVE SUMMARY

2 MARKET INTRODUCTION

2.1 DEFINITION 13

2.2 SCOPE OF THE STUDY 13

2.3 RESEARCH OBJECTIVE 13

2.4 MARKET STRUCTURE 14

3 RESEARCH METHODOLOGY

3.1 RESEARCH PROCESS 15

3.2 PRIMARY RESEARCH 16

3.3 SECONDARY RESEARCH 17

3.4 MARKET SIZE ESTIMATION 18

3.5 FORECAST MODEL 19

3.6 LIST OF ASSUMPTIONS 20

4 MARKET DYNAMICS

4.1 INTRODUCTION 21

4.2 DRIVERS 22

4.2.1 INCREASING PREVALENCE OF KIDNEY CANCER AND CHRONIC KIDNEY DISEASES 22

4.2.2 RISING NUMBER OF LAPAROSCOPIC NEPHRECTOMY PROCEDURES 22

4.2.3 INCREASING AWARENESS AND DEMAND FOR ORGAN (KIDNEY) TRANSPLANT 22

4.2.4 DRIVERS IMPACT ANALYSIS 23

4.3 RESTRAINTS 24

4.3.1 RISKS AND COMPLICATIONS OF THE NEPHRECTOMY SURGERY 24

4.3.2 HIGH COST RELATED OF THE PROCEDURE 24

4.3.3 RESTRAINTS IMPACT ANALYSIS 24

4.4 OPPORTUNITIES 25

4.4.1 TECHNOLOGICAL ADVANCEMENTS IN LAPAROSCOPY NEPHRECTOMY 25

5 MARKET FACTOR ANALYSIS

5.1 PORTER’S FIVE FORCES MODEL 26

5.1.1 BARGAINING POWER OF SUPPLIERS 26

5.1.2 BARGAINING POWER OF BUYERS 26

5.1.3 THREAT OF NEW ENTRANTS 27

5.1.4 THREAT OF SUBSTITUTES 27

5.1.5 INTENSITY OF RIVALRY 27

5.2 VALUE CHAIN ANALYSIS 28

5.2.1 R&D AND DESIGNING 29

5.2.2 MANUFACTURING 29

5.2.3 DISTRIBUTION 29

5.2.4 MARKETING & SALES 29

5.2.5 POST-SALES MONITORING 29

5.3 PRICING ANALYSIS 30

6 NEPHRECTOMY MARKET, BY PROCEDURE

6.1 OVERVIEW 31

6.2 LAPAROSCOPIC NEPHRECTOMY 32

6.3 ROBOT-ASSISTED LAPAROSCOPIC NEPHRECTOMY 33

6.4 OPEN NEPHRECTOMY 33

7 NEPHRECTOMY MARKET, BY INDICATION

7.1 OVERVIEW 34

7.2 KIDNEY CANCER 35

7.3 OTHER KIDNEY DISEASES 36

8 NEPHRECTOMY MARKET, BY END USER

8.1 OVERVIEW 37

8.2 HOSPITALS & CLINICS 38

8.3 SURGICAL CENTERS 38

9 GLOBAL NEPHRECTOMY MARKET, BY REGION

9.1 OVERVIEW 39

9.2 AMERICAS 41

NEPHRECTOMY MARKET, BY PROCEDURE

NEPHRECTOMY MARKET, BY INDICATION

NEPHRECTOMY MARKET, BY END USER

9.2.1 NORTH AMERICA 42

NEPHRECTOMY MARKET, BY PROCEDURE

NEPHRECTOMY MARKET, BY INDICATION

NEPHRECTOMY MARKET, BY END USER

9.2.1.1 US 44

NEPHRECTOMY MARKET, BY PROCEDURE

NEPHRECTOMY MARKET, BY INDICATION

NEPHRECTOMY MARKET, BY END USER

9.2.1.2 CANADA 45

NEPHRECTOMY MARKET, BY PROCEDURE

NEPHRECTOMY MARKET, BY INDICATION

NEPHRECTOMY MARKET, BY END USER

9.2.2 LATIN AMERICA 46

NEPHRECTOMY MARKET, BY PROCEDURE

NEPHRECTOMY MARKET, BY INDICATION

NEPHRECTOMY MARKET, BY END USER

9.3 EUROPE 48

NEPHRECTOMY MARKET, BY PROCEDURE

NEPHRECTOMY MARKET, BY INDICATION

NEPHRECTOMY MARKET, BY END USER

9.3.1 WESTERN EUROPE 49

NEPHRECTOMY MARKET, BY PROCEDURE

NEPHRECTOMY MARKET, BY INDICATION

NEPHRECTOMY MARKET, BY END USER

9.3.2 GERMANY 51

NEPHRECTOMY MARKET, BY PROCEDURE

NEPHRECTOMY MARKET, BY INDICATION

NEPHRECTOMY MARKET, BY END USER

9.3.3 FRANCE 52

NEPHRECTOMY MARKET, BY PROCEDURE

NEPHRECTOMY MARKET, BY INDICATION

NEPHRECTOMY MARKET, BY END USER

9.3.4 UK 53

NEPHRECTOMY MARKET, BY PROCEDURE

NEPHRECTOMY MARKET, BY INDICATION

NEPHRECTOMY MARKET, BY END USER

9.3.5 ITALY 54

NEPHRECTOMY MARKET, BY PROCEDURE

NEPHRECTOMY MARKET, BY INDICATION

NEPHRECTOMY MARKET, BY END USER

9.3.6 SPAIN 55

NEPHRECTOMY MARKET, BY PROCEDURE

NEPHRECTOMY MARKET, BY INDICATION

NEPHRECTOMY MARKET, BY END USER

9.3.7 REST OF WESTERN EUROPE 56

NEPHRECTOMY MARKET, BY PROCEDURE

NEPHRECTOMY MARKET, BY INDICATION

NEPHRECTOMY MARKET, BY END USER

9.3.8 EASTERN EUROPE 57

NEPHRECTOMY MARKET, BY PROCEDURE

NEPHRECTOMY MARKET, BY INDICATION

NEPHRECTOMY MARKET, BY END USER

9.4 ASIA-PACIFIC 58

NEPHRECTOMY MARKET, BY PROCEDURE

NEPHRECTOMY MARKET, BY INDICATION

NEPHRECTOMY MARKET, BY END USER

9.4.1 CHINA 60

NEPHRECTOMY MARKET, BY PROCEDURE

NEPHRECTOMY MARKET, BY INDICATION

NEPHRECTOMY MARKET, BY END USER

9.4.2 INDIA 61

NEPHRECTOMY MARKET, BY PROCEDURE

NEPHRECTOMY MARKET, BY INDICATION

NEPHRECTOMY MARKET, BY END USER

9.4.3 JAPAN 62

NEPHRECTOMY MARKET, BY PROCEDURE

NEPHRECTOMY MARKET, BY INDICATION

NEPHRECTOMY MARKET, BY END USER

9.4.4 AUSTRALIA 63

NEPHRECTOMY MARKET, BY PROCEDURE

NEPHRECTOMY MARKET, BY INDICATION

NEPHRECTOMY MARKET, BY END USER

9.4.5 SOUTH KOREA 64

NEPHRECTOMY MARKET, BY PROCEDURE

NEPHRECTOMY MARKET, BY INDICATION

NEPHRECTOMY MARKET, BY END USER

9.4.6 REST OF ASIA-PACIFIC 65

NEPHRECTOMY MARKET, BY PROCEDURE

NEPHRECTOMY MARKET, BY INDICATION

NEPHRECTOMY MARKET, BY END USER

9.5 REST OF THE WORLD (ROW) 66

NEPHRECTOMY MARKET, BY PROCEDURE

NEPHRECTOMY MARKET, BY INDICATION

NEPHRECTOMY MARKET, BY END USER

10 COMPETITIVE LANSCAPE 67

NEPHRECTOMY MARKET, BY PROCEDURE

NEPHRECTOMY MARKET, BY INDICATION

NEPHRECTOMY MARKET, BY END USER

10.1 OVERVIEW 67

10 COMPANY PROFILES

11.1 KARL STORZ SE & CO. KG 68

11.1.1 COMPANY OVERVIEW 68

11.1.2 FINANCIAL OVERVIEW 68

11.1.3 PRODUCTS/SERVICES OFFERED 68

11.1.4 KEY DEVELOPMENTS 68

11.1.5 SWOT ANALYSIS 69

11.1.6 KEY STRATEGIES 69

11.2 OLYMPUS CORPORATION 70

11.2.1 COMPANY OVERVIEW 70

11.2.2 FINANCIAL OVERVIEW 70

11.2.3 PRODUCTS/SERVICES OFFERED 71

11.2.4 KEY DEVELOPMENTS 71

11.2.5 SWOT ANALYSIS 72

11.2.6 KEY STRATEGIES 72

11.3 MEDTRONIC 73

11.3.1 COMPANY OVERVIEW 73

11.3.2 FINANCIAL OVERVIEW 73

11.3.3 PRODUCTS/SERVICES OFFERED 74

11.3.4 KEY DEVELOPMENTS 74

11.3.5 SWOT ANALYSIS 75

11.3.6 KEY STRATEGIES 75

11.4 B. BRAUN MELSUNGEN AG 76

11.4.1 COMPANY OVERVIEW 76

11.4.2 FINANCIAL OVERVIEW 76

11.4.3 PRODUCTS/SERVICES OFFERED 77

11.4.4 KEY DEVELOPMENTS 77

11.4.5 SWOT ANALYSIS 78

11.4.6 KEY STRATEGIES 78

11.5 JOHNSON & JOHNSON SERVICES, INC. 79

11.5.1 COMPANY OVERVIEW 79

11.5.2 FINANCIAL OVERVIEW 79

11.5.3 PRODUCTS/SERVICES OFFERED 80

11.5.4 KEY DEVELOPMENTS 80

11.5.5 SWOT ANALYSIS 81

11.5.6 KEY STRATEGIES 81

11.6 COOK GROUP 82

11.6.1 COMPANY OVERVIEW 82

11.6.2 FINANCIAL OVERVIEW 82

11.6.3 PRODUCTS/SERVICES OFFERED 82

11.6.4 KEY DEVELOPMENTS 82

11.6.5 SWOT ANALYSIS 83

11.6.6 KEY STRATEGIES 83

11.7 CONMED CORPORATION 84

11.7.1 COMPANY OVERVIEW 84

11.7.2 FINANCIAL OVERVIEW 84

11.7.3 PRODUCTS/SERVICES OFFERED 85

11.7.4 KEY DEVELOPMENTS 85

11.7.5 SWOT ANALYSIS 86

11.7.6 KEY STRATEGIES 86

11.8 XCELLANCE MEDICAL TECHNOLOGIES 87

11.8.1 COMPANY OVERVIEW 87

11.8.2 FINANCIAL OVERVIEW 87

11.8.3 PRODUCTS/SERVICES OFFERED 87

11.8.4 KEY DEVELOPMENTS 87

11.8.5 SWOT ANALYSIS 88

11.8.6 KEY STRATEGIES 88

11 APPENDIX

12.1 REFERENCES 89

12.2 RELATED REPORTS 89

12 LIST OF TABLES

TABLE 1 PRIMARY INTERVIEWS 16

TABLE 2 LIST OF ASSUMPTIONS 20

TABLE 3 GLOBAL NEPHRECTOMY MARKET, BY PROCEDURE, 2020–2027 (USD MILLION) 31

TABLE 4 GLOBAL NEPHRECTOMY MARKET FOR LAPAROSCOPIC NEPHRECTOMY, BY REGION 2020–2027 (USD MILLION) 32

TABLE 5 GLOBAL NEPHRECTOMY MARKET FOR ROBOT-ASSISTED LAPAROSCOPIC NEPHRECTOMY, BY REGION 2020–2027

(USD MILLION) 33

TABLE 6 GLOBAL NEPHRECTOMY MARKET FOR OPEN NEPHRECTOMY, BY REGION 2020–2027 (USD MILLION) 33

TABLE 7 GLOBAL NEPHRECTOMY MARKET, BY INDICATION, 2020–2027 (USD MILLION) 34

TABLE 8 GLOBAL NEPHRECTOMY MARKET FOR KIDNEY CANCER, BY REGION 2020–2027 (USD MILLION) 35

TABLE 9 GLOBAL NEPHRECTOMY MARKET FOR OTHER KIDNEY DISEASES, BY REGION 2020–2027 (USD MILLION) 36

TABLE 10 GLOBAL NEPHRECTOMY MARKET, BY END USER, 2020–2027 (USD MILLION) 37

TABLE 11 GLOBAL NEPHRECTOMY MARKET FOR HOSPITALS & CLINICS, BY REGION 2020–2027 (USD MILLION) 38

TABLE 12 GLOBAL NEPHRECTOMY MARKET FOR SURGICAL CENTERS, BY REGION 2020–2027 (USD MILLION) 38

TABLE 13 GLOBAL NEPHRECTOMY MARKET, BY REGION, 2020–2027 (USD MILLION) 39

TABLE 14 AMERICAS: NEPHRECTOMY MARKET, BY REGION, 2020–2027 (USD MILLION) 41

TABLE 15 AMERICAS: NEPHRECTOMY MARKET, BY PROCEDURE, 2020–2027 (USD MILLION) 41

TABLE 16 AMERICAS: NEPHRECTOMY MARKET, BY INDICATION, 2020–2027 (USD MILLION) 42

TABLE 17 AMERICAS: NEPHRECTOMY MARKET, BY END-USER, 2020–2027 (USD MILLION) 42

TABLE 18 AMERICAS: NEPHRECTOMY MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 42

TABLE 19 NORTH AMERICA: NEPHRECTOMY MARKET, BY PROCEDURE, 2020–2027 (USD MILLION) 43

TABLE 20 NORTH AMERICA: NEPHRECTOMY MARKET, BY INDICATION, 2020–2027 (USD MILLION) 43

TABLE 21 NORTH AMERICA: NEPHRECTOMY MARKET, BY END-USER, 2020–2027 (USD MILLION) 44

TABLE 22 US: NEPHRECTOMY MARKET, BY PROCEDURE, 2020–2027 (USD MILLION) 44

TABLE 23 US: NEPHRECTOMY MARKET, BY INDICATION, 2020–2027 (USD MILLION) 44

TABLE 24 US: NEPHRECTOMY MARKET, BY END-USER, 2020–2027 (USD MILLION) 45

TABLE 25 CANADA: NEPHRECTOMY MARKET, BY PROCEDURE, 2020–2027 (USD MILLION) 45

TABLE 26 CANADA: NEPHRECTOMY MARKET, BY INDICATION, 2020–2027 (USD MILLION) 45

TABLE 27 CANADA: NEPHRECTOMY MARKET, BY END-USER, 2020–2027 (USD MILLION) 46

TABLE 28 LATIN AMERICA: NEPHRECTOMY MARKET, BY PROCEDURE, 2020–2027 (USD MILLION) 46

TABLE 29 LATIN AMERICA: NEPHRECTOMY MARKET, BY INDICATION, 2020–2027 (USD MILLION) 46

TABLE 30 LATIN AMERICA: NEPHRECTOMY MARKET, BY END-USER, 2020–2027 (USD MILLION) 47

TABLE 31 EUROPE: NEPHRECTOMY MARKET, BY REGION, 2020–2027 (USD MILLION) 48

TABLE 32 EUROPE: NEPHRECTOMY MARKET, BY PROCEDURE, 2020–2027 (USD MILLION) 48

TABLE 33 EUROPE: NEPHRECTOMY MARKET, BY INDICATION, 2020–2027 (USD MILLION) 49

TABLE 34 EUROPE: NEPHRECTOMY MARKET, BY END-USER, 2020–2027 (USD MILLION) 49

TABLE 35 WESTERN EUROPE: NEPHRECTOMY MARKET, BY COUNTRY/REGION, 2020–2027 (USD MILLION) 49

TABLE 36 WESTERN EUROPE: NEPHRECTOMY MARKET, BY PROCEDURE, 2020–2027 (USD MILLION) 50

TABLE 37 WESTERN EUROPE: NEPHRECTOMY MARKET, BY INDICATION, 2020–2027 (USD MILLION) 50

TABLE 38 WESTERN EUROPE: NEPHRECTOMY MARKET, BY END-USER, 2020–2027 (USD MILLION) 51

TABLE 39 GERMANY: NEPHRECTOMY MARKET, BY PROCEDURE, 2020–2027 (USD MILLION) 51

TABLE 40 GERMANY: NEPHRECTOMY MARKET, BY INDICATION, 2020–2027 (USD MILLION) 51

TABLE 41 GERMANY: NEPHRECTOMY MARKET, BY END-USER, 2020–2027 (USD MILLION) 52

TABLE 42 FRANCE: NEPHRECTOMY MARKET, BY PROCEDURE, 2020–2027 (USD MILLION) 52

TABLE 43 FRANCE: NEPHRECTOMY MARKET, BY INDICATION, 2020–2027 (USD MILLION) 52

TABLE 44 FRANCE: NEPHRECTOMY MARKET, BY END-USER, 2020–2027 (USD MILLION) 53

TABLE 45 UK: NEPHRECTOMY MARKET, BY PROCEDURE, 2020–2027 (USD MILLION) 53

TABLE 46 UK: NEPHRECTOMY MARKET, BY INDICATION, 2020–2027 (USD MILLION) 53

TABLE 47 UK: NEPHRECTOMY MARKET, BY END-USER, 2020–2027 (USD MILLION) 54

TABLE 48 ITALY: NEPHRECTOMY MARKET, BY PROCEDURE, 2020–2027 (USD MILLION) 54

TABLE 49 ITALY: NEPHRECTOMY MARKET, BY INDICATION, 2020–2027 (USD MILLION) 54

TABLE 50 ITALY: NEPHRECTOMY MARKET, BY END-USER, 2020–2027 (USD MILLION) 55

TABLE 51 SPAIN: NEPHRECTOMY MARKET, BY PROCEDURE, 2020–2027 (USD MILLION) 55

TABLE 52 SPAIN: NEPHRECTOMY MARKET, BY INDICATION, 2020–2027 (USD MILLION) 55

TABLE 53 SPAIN: NEPHRECTOMY MARKET, BY END-USER, 2020–2027 (USD MILLION) 56

TABLE 54 REST OF WESTERN EUROPE: NEPHRECTOMY MARKET, BY PROCEDURE, 2020–2027 (USD MILLION) 56

TABLE 55 REST OF WESTERN EUROPE: NEPHRECTOMY MARKET, BY INDICATION, 2020–2027 (USD MILLION) 56

TABLE 56 REST OF WESTERN EUROPE: NEPHRECTOMY MARKET, BY END-USER, 2020–2027 (USD MILLION) 57

TABLE 57 EASTERN EUROPE: NEPHRECTOMY MARKET, BY PROCEDURE, 2020–2027 (USD MILLION) 57

TABLE 58 EASTERN EUROPE: NEPHRECTOMY MARKET, BY INDICATION, 2020–2027 (USD MILLION) 57

TABLE 59 EASTERN EUROPE: NEPHRECTOMY MARKET, BY END-USER, 2020–2027 (USD MILLION) 58

TABLE 60 ASIA-PACIFIC: NEPHRECTOMY MARKET, BY COUNTRY/REGION, 2020–2027 (USD MILLION) 58

TABLE 61 ASIA PACIFIC: NEPHRECTOMY MARKET, BY PROCEDURE, 2020–2027 (USD MILLION) 59

TABLE 62 ASIA PACIFIC: NEPHRECTOMY MARKET, BY INDICATION, 2020–2027 (USD MILLION) 59

TABLE 63 ASIA PACIFIC: NEPHRECTOMY MARKET, BY END-USER, 2020–2027 (USD MILLION) 59

TABLE 64 CHINA: NEPHRECTOMY MARKET, BY PROCEDURE, 2020–2027 (USD MILLION) 60

TABLE 65 CHINA: NEPHRECTOMY MARKET, BY INDICATION, 2020–2027 (USD MILLION) 60

TABLE 66 CHINA: NEPHRECTOMY MARKET, BY END-USER, 2020–2027 (USD MILLION) 60

TABLE 67 INDIA: NEPHRECTOMY MARKET, BY PROCEDURE, 2020–2027 (USD MILLION) 61

TABLE 68

Purchase Option
	Single User	$ 4,950
	Multiuser License	$ 5,950
	Enterprise User	$ 7,250
Compare Licenses

Tailored for You

Dedicated Research on any specifics segment or region.
Focused Research on specific players in the market.
Custom Report based only on your requirements.
Flexibility to add or subtract any chapter in the study.
Historic data from 2014 and forecasts outlook till 2040.
Flexibility of providing data/insights in formats (PDF, PPT, Excel).
Provide cross segmentation in applicable scenario/markets.

Related Reports

US Nephrectomy Market

Alport Syndrome Market Research Report- Global Forecast till 2032

Press Release

Nephrectomy Market Size Expected to Grow at a CAGR over 4.20% from 2022 to 2030

FEATURES	LICENCE TYPE
FEATURES	Single User	Multiuser Licence	Enterprise User
Price	$ 4,950	$ 5,950	$ 7,250
Maximum User Access Limit	1 User	Upto 10 Users	Unrestricted Access Throughout The Organization.
Free Customization
Direct access to the Analyst
Deliverable Format
Deliverable Format
Platform Access
Discount on Your Next Purchase	10%	15%	10%
Printable Versions

© 2025 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)